Martin-Otal et al. created CAR-T cells targeting extra domain A (EDA) of fibronectin; this domain is a splice variant being expressed in many malignancies and also in the endothelial basement membrane of tumor vasculature [81]. Here, FN1 is linked to neoplasm.